Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

NCT00230308CI-TRIAL-00099593recruitingClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Head and Neck Cancer	Malignant Head and Neck Neoplasm	ALIAS	0.90

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

All patients undergoing surgery at Stanford University for head and neck cancer.

Exclusion Criteria:

Non-Stanford patients.

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Apr 2, 2002
Primary completion: Jun 1, 2030
Completion: Dec 1, 2030
First posted: Sep 30, 2005
Last update posted: Dec 24, 2025
Enrollment: 500 (estimated)
Lead sponsor: Stanford University OTHER
Collaborators: National Cancer Institute (NCI); National Institutes of Health (NIH); National Institute of Dental and Craniofacial Research (NIDCR)
Keywords: Head and Neck Cancer

Data updated 22 days agoSource updated Dec 24, 2025source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
United States	1	1

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.